Inventor
Hermona Soreq
Inventor
Jerusalem, IL
Overview
Patents· 22 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C12Nprimary
C12NMicroorganisms or enzymes24%
A61KPreparations for medical, dental or toiletry purposes18%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations15%
C12YEnzymes11%
A01KAnimal husbandry8%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms8%
C07KPeptides5%
G01NInvestigating or analysing materials by determining their chemical or physical properties3%
B33YAdditive manufacturing, i.e. manufacturing of three-dimensional [3d] objects by additive deposition, additive agglomeration or additive layering, e.g. by 3d printing, stereolithography or selective laser sintering2%
B82YSpecific uses or applications of nanostructures2%
PatentTitleYear
10,442,944Hybrid nanoparticles as photoinitiators201910,174,320Downregulating miR-132 for the treatment of lipid related disorders20198,722,876'Antisense oligonucleotides against AChE in the treatment of gastrointestinal inflammation disorders'20147,838,493'Acetylcholinesterase (ACHE)-derived peptide as an inducer of granulocytopoiesis, uses and methods thereof'20107,494,783'Method for assessing trait anxiety by determining cholinergic status'20097,456,154'Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof'20087,074,915'Antisense oligonucleotide against human acetylcholinesterase (AChE) and uses thereof'20067,067,486'Acetylcholinesterase-derived peptides and uses thereof'20067,063,948'Uses of antibodies against AChE and peptides thereof'20066,987,211'Transgenic non-human mammals producing a cholinesterase in their milk'20066,770,799'Expression of recombinant human acetylcholinesterase in transgenic plants'20046,475,998'Methods and compositions for the treatment of injury to the central nervous system'20026,326,139'Method of screening for genetic predisposition to anticholinesterase therapy'20016,258,780'Method and composition for enabling passage through the blood-brain-barrier'20016,121,046'Synthetic antisense oligodeoxynucleotides targeted to human ache'20006,110,742'Synthetic antisense oligodeoxynucleotides targeted to AChE'20006,025,183'Transgenic animal assay system for anti-cholinesterase substances'20005,932,780'Transgenic non-human animal assay system for anti-cholinesterase substances'19995,891,725'Synthetic antisense oligodeoxynucleotides and pharmaceutical compositions containing them'19995,807,671'Method of screening for genetic predisposition to anticholinesterase therapy'19985,595,903'Genetically engineered human acetylcholinesterase'19975,215,909'Human cholinesterase genes'1993Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1993Patents assigned to YEDA RES & DEV (1)· patent assignee history
1993–2001Based in Rishon Lezion, IL· patent location history
1997–2014Patents assigned to YISSUM RES DEV CO (18)· patent assignee history
1998Based in Rishon Leziyon, IL· patent location history
2000–2019Based in Jerusalem, IL· patent location history
2000Based in Kerem Maharal, IL· patent location history
2004Patents assigned to THOMPSON BOYCE PLANT RES (1)· patent assignee history
2010Patents assigned to MEDICAL RES FUND AT THE TEL AV (1)· patent assignee history
2019Patents assigned to YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| YISSUM RES DEV CO | 18 | 1997–2014 |
| YISSUM RES DEV CO OF HEBREW UNIV JERUSALEM LTD | 2 | 2019 |
| MEDICAL RES FUND AT THE TEL AV | 1 | 2010 |
| THOMPSON BOYCE PLANT RES | 1 | 2004 |
| YEDA RES & DEV | 1 | 1993 |
Locations
| Location | Patents | Span |
|---|---|---|
| Jerusalem, IL | 14 | 2000–2019 |
| Rishon Lezion, IL | 6 | 1993–2001 |
| Kerem Maharal, IL | 1 | 2000 |
| Rishon Leziyon, IL | 1 | 1998 |